Sanxin Medtec(SZ:300453) Zheng Quan Zhi Xing·2025-08-08 12:13Core Points - The company has approved the first unlock period of the 2024 restricted stock incentive plan, confirming that the conditions for unlocking have been met [2][4] - A total of 112 individuals are eligible for the unlock, having satisfied the necessary conditions outlined in the incentive plan [3][4] - The company will adjust the repurchase price and cancel 313,250 shares of restricted stock that do not meet the unlock conditions [5] Summary by Sections Unlock Conditions - The company has verified that it meets the qualifications to implement the stock incentive plan and has not encountered any disqualifying events [2] - Specific disqualifying events include negative audit opinions, improper profit distribution, and other regulatory restrictions [2][3] Eligible Participants - The monitoring committee has confirmed that all 112 individuals on the unlock list meet the criteria set forth in the incentive plan [3][4] - The criteria include not being deemed inappropriate by regulatory bodies within the last 12 months and not having any major legal violations [3] Repurchase and Cancellation - The monitoring committee has approved the adjustment of the repurchase price for the restricted stock and the cancellation of shares that do not meet the unlock conditions [4][5] - The repurchase and cancellation process is deemed compliant with relevant regulations and will not adversely affect the company's financial status [4]